-
Waiting and waiting on Dopamine transporter imaging in drug induced parkinsonism
-
Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting
-
Wearable versus marker-free technologies: does it matter for clinical gait analysis?
-
Weighting fibroblasts for future diagnostic prospect
-
WES analysis of Parkinson’s disease patients with Cancer
-
What can predict short and long-term outcome of bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease?
-
What connectivity tells us about neurodegeneration in Huntington disease? A fMRI study
-
What do medical students think about functional movement disorders?
-
What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease
-
White matter abnormalities correlate with clinical features in PSP patients
-
White matter and subcortical volume of essential tremor patient decreases after MR-guided focused ultrasound thalamotomy
-
Whole Exome Sequencing Identifies a Homozygous POLG2 Missense Variant in an adult patient presenting with movement disorders and Mitochondrial DNA Depletion
-
Whole-Body Neuromuscular Ultrasound for Evaluating Posture and Targeted Management of Muscle Spasticity and Pain
-
Wide distribution of alpha-synuclein oligomers in Creutzfeldt-Jakob disease detected by a novel proximity ligation assay
-
Widespread distribution and abundant accumulation of alpha-synuclein oligomers in multiple system atrophy brain
-
Wilson disease: a systematic review and meta-analysis in phenotype – genotype correlations
-
Wilson’s disease in Finland
-
Wislon disease: clinical specificities of the disease course under normal ceruloplasmin in the blood, a clinical case from Kyrgyzstan
2019 International Congress
September 22-26, 2019. Nice, France.